A Hidden Clue to Lifelong Health: The Height-GaP
Study by Ben Smith introduces height-GaP, a simple measure linking early-life growth adversity to adult mortality risk, revealing how childhood conditions shape lifelong health.
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Study by Ben Smith introduces height-GaP, a simple measure linking early-life growth adversity to adult mortality risk, revealing how childhood conditions shape lifelong health.
Darcy Wagner is pioneering 3D-printed lung tissue to repair damaged airways, paving the way for personalized respiratory treatments
Deborah Assayag’s team receive D2R funding to identify blood-based markers that could enable earlier diagnosis and more personalized treatment of ILD
Carolyn Baglole discuss the SQDC’s decision to sell cannabis vape products and why “regulated” should not be confused with “safe”
Maziar Divangahi discusses his research on β-glucan and lung inflammation with Radio-Canada
Larry Lands and Darcy Wagner and team are developing an mRNA therapy to correct genetic errors in primary ciliary dyskinesia, opening new paths for treatment
A major eLife Focus Issue highlights 10+ years of trained immunity research, featuring key contributions from Meakins scientists
Irah King receives MI4 funding to explore how alterations in the gut microbiome may drive the development of fibromyalgia
Study by Jonathon Campbell shows that scaling up existing TB screening and preventive treatments will save lives and costs
Several RESP Program researchers are among the recipients of the Montreal General Hospital Foundation’s 2025 Research Awards